Evaluation of anticoagulation and nonsurgical major bleeding in recipients of continuous‐flow left ventricular assist devices

Continuous‐flow left ventricular assist device (LVAD) placement has become a standard of care in advanced heart failure treatment. Bleeding is the most frequently reported adverse event after LVAD implantation and may be increased by antithrombotic agents used for prevention of pump thrombosis. This...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Artificial organs Ročník 43; číslo 8; s. 736 - 744
Hlavní autoři:	Veasey, Tara M., Floroff, Catherine K., Strout, Sara E., McElray, Krista L., Brisco‐Bacik, Meredith A., Cook, Jennifer L., Toole, John M., Craig, Michael L., Van Bakel, Adrian B., Meadows, Holly B., Uber, Walter E.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States Wiley Subscription Services, Inc 01.08.2019
Témata:	Aged Anticoagulants Anticoagulants - adverse effects Anticoagulants - therapeutic use anticoagulation Bleeding Blood Coagulation - drug effects Congestive heart failure Erythrocytes Female Heart Heart-Assist Devices - adverse effects Hemoglobin Hemorrhage Hemorrhage - etiology Hemorrhage - therapy Humans Implantation Incidence Intracranial Hemorrhages - etiology Intracranial Hemorrhages - therapy left ventricular assist device LVAD Male Middle Aged Renal function Retrospective Studies Thromboembolism Thrombosis Thrombosis - prevention & control Ventricle Ventricular assist devices bleeding left ventricular assist device LVAD anticoagulation
ISSN:	0160-564X, 1525-1594, 1525-1594
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!